CRBP

← Markets

CRBPCorbus Pharmaceuticals Holdings, Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Thu, Aug 6
7:00 AMYahooCorbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
Tue, Aug 4
7:30 AMYahooCorbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
Tue, Jul 28
7:00 AMYahooCorbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer
Mon, Jul 6
7:00 AMYahooCorbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
Tue, Jun 9
4:02 AMmarketbeat.comCorbus Pharmaceuticals Teases Cancer, Obesity Data as Key Clinical Readouts Near
Mon, Jun 1
9:04 AMmarketbeat.comCorbus Pharmaceuticals Targets HPV-Linked Head and Neck Cancer With CRB-701 Study
Tue, May 26
6:00 AMYahooCorbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers
Fri, May 22
2:04 AMmarketbeat.comCorbus Pharmaceuticals Teases Key ASCO Cancer Data, Late-Summer Obesity Readout
Thu, May 21
7:00 AMYahooCorbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
Thu, May 14
7:00 AMYahooCorbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors
Wed, May 13
6:00 AMYahooCorbus Pharmaceuticals to Participate in Upcoming Investor Conferences
Tue, May 12
7:00 AMYahooCorbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update